Close Menu

This article from the Wall Street Journal examines some of the changes expected as Pfizer unveils its new strategy with its latest chief, Jeffrey Kindler, at the helm. "His plan is likely to involve shedding more jobs and rethinking the way the drug giant develops, makes and markets medicines," according to the story. Analysts are anticipating the new vision to be laid out for the public next Monday.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.